Stock Chart

AURA

$6.09 +0.83%
Score: 60.9 HOLD
Pro
Screener
Vol: 2.28x (vs SPY: 2.3x | vs QQQ: 2.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Bear Flag Bearish scenario quality 73/100
Setup invalidates on a close above $6.26 · pole −22% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks down 69% of the time (n=379) — the only flag with real bearish follow-through. Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About AURA - Aura Biosciences, Inc. Common Stock

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Key Statistics

Market Cap $626M

This AURA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AURA's price movements with trendlines, gamma walls, and key support/resistance levels.